Research News on Planning Your Treatment
-
Most Women Need More Tests After Lumpectomy for DCIS
Most women who have lumpectomy to remove DCIS need more procedures -- diagnostic mammograms and/or biopsies -- on the same breast in the 10 years after lumpectomy.
-
Controversial Study Suggests Large Margins Reduce Recurrence Risk
Findings from a controversial study suggest that women who have lumpectomy to remove DCIS are less likely to have cancer come back in the same breast when at least 10 mm. of cancer-free tissue around the DCIS is removed during surgery.
-
About 25% of Women Need More Surgery After Lumpectomy
A study found that nearly 25% of women who had lumpectomy had to have more surgery after the pathology report was available.
-
When Breast Cancer Doctors Collaborate, Women More Satisfied
A study found that women whose doctors actively collaborated throughout the course of breast cancer treatment were more satisfied with their treatment than women whose doctors didn't collaborate.
-
Arimidex-Faslodex Combo Improves Survival in Metastatic Breast Cancer
A study has found that postmenopausal women diagnosed with hormone-receptor-positive metastatic breast cancer and treated with a combination of Arimidex and Faslodex as the first treatment for metastatic disease lived 6 months longer than women treated only with Arimidex.
-
Femara Offers More Benefits Than Tamoxifen After Breast Cancer Surgery
New results boost evidence that postmenopausal women get more benefits from 5 years of Femara compared to 5 years of tamoxifen after surgery for early-stage, hormone-receptor-positive breast cancer.
-
Hormonal Therapy Before Surgery May Be Good Treatment for Postmenopausal Women with Hormone-Receptor-Positive, Locally Advanced Disease
Research suggests that hormonal therapy before surgery may be a good alternative to chemotherapy before surgery for postmenopausal women diagnosed with hormone-receptor-positive breast cancer.
-
“Personality” of Cancer Affects Recurrence Risk After Lumpectomy, Not When Chemo is Given
A study has found that cancer characteristics, not the timing of chemotherapy, affect the risk of recurrence in women diagnosed with early-stage breast cancer who had lumpectomy.
-
No Difference in Prognosis with Sentinel Node Biopsy Versus Axillary Node Biopsy
Research shows that women who had sentinel node biopsy did just as well as women who had axillary node biopsy, even though small clusters of breast cancer cells may have been in the axillary lymph nodes of the women who had sentinel node biopsy.
-
Lumpectomy and Radiation Therapy as Good as Mastectomy for Younger Women
Research shows that young women who had lumpectomy followed by radiation therapy were no more likely to have the breast cancer come back and just as likely to survive breast cancer as young women who had mastectomy.
